ArticleGeroScience2026
Resting heart rate and cognitive function in ageing: Insights from a secondary data analysis.
Article in GeroScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Resting heart rate (RHR) is an accessible measure that may reflect age-related cardiovascular and autonomic dysregulation relevant to cognitive ageing. However, evidence linking RHR with cognitive outcomes is inconsistent, and most studies relied on single baseline measurements that may not capture cumulative exposure. This study examined the associations of baseline and longitudinally averaged RHR with cognitive decline and dementia in older adults. This was a secondary analysis of the ASPirin in Reducing Events in the Elderly (ASPREE) study, including 19,114 community-dwelling participants aged ≥ 65 years without cardiovascular disease or dementia at baseline. RHR was assessed at baseline and follow-up visits using an oscillometric device. Cognitive decline was defined as a decrease of > 1.5 standard deviations from baseline performance in global cognition, episodic memory, psychomotor speed, or verbal fluency. Incident dementia was adjudicated using DSM-IV criteria. Compared with baseline RHR of 60-69 bpm, those with RHR ≥ 80 bpm had a 9% higher cognitive decline risk (hazard ratio [HR] 1.09; 95% confidence interval [CI], 1.01-1.18). Five-year average RHR of 70-79 bpm and ≥ 80 bpm were associated with 10% (HR 1.10; 95% CI, 1.03-1.19) and 16% (HR 1.16; 95% CI, 1.05-1.28) higher cognitive decline risks, respectively. No significant associations were observed with incident dementia. Higher RHR was associated with increased risk of cognitive decline among older adults. These findings suggest that elevated RHR may reflect age-related cardiovascular or autonomic physiological processes relevant to cognitive aging, supporting a role for late-life physiological dysregulation in cognitive trajectories.
Indexed as
Identifiers
42329536What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.